Histone deacetylase inhibition overcomes rapamycin resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling via mTORC2 - Evidence review
In diffuse large B-cell lymphoma, cell and tumor studies show rapamycin can trigger AKT activation via mTORC2; HDAC inhibition may counter this response.
Authors
- Melania Mondini (ORCID: https://orcid.org/0009-0008-5005-7693)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.5281/zenodo.24366841
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00